Texas Ibogaine, Australia Veterans, and Freedom to Heal
This month, the strongest policy signal is that access is being built from multiple directions at once. Texas is using state dollars to stand up an ibogaine clinical trial consortium, federal lawmakers are trying to unlock a pre-approval access pathway for Schedule I psychedelics, and health systems abroad are moving from “permission” to “payment” with tighter delivery rules.
